Experiment: 5MBR

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-1H NOESY	0.59 mM DNA, 10.0 mM potassium phosphate	90% H2O/10% D2O	10 mM	7.0	1 atm	298	Bruker AVANCE 600
2	2D 1H-13C HSQC aromatic	0.59 mM DNA, 10.0 mM potassium phosphate	90% H2O/10% D2O	10 mM	7.0	1 atm	298	Bruker AVANCE 600
3	2D DQF-COSY	0.59 mM DNA, 10.0 mM potassium phosphate	100% D2O	10 mM	7.0	1 atm	298	Bruker AVANCE 600
4	2D HMBC	0.59 mM DNA, 10.0 mM potassium phosphate	90% H2O/10% D2O	10 mM	7.0	1 atm	298	Bruker AVANCE 600
5	2D 1H-1H NOESY	0.59 mM DNA, 10.0 mM potassium phosphate	100% D2O	10 mM	7.0	1 atm	298	Bruker AVANCE 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing		Amber

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	10
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	Amber	14	Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman
2	structure calculation	Xplor-NIH	2.39	Schwieters, Kuszewski, Tjandra and Clore
3	chemical shift assignment	CcpNmr Analysis	2.2	CCPN
4	peak picking	CcpNmr Analysis	2.1	CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.